Related Experiment Video
Updated: Oct 18, 2025

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent
Xinyi Li1,2, Zengxin Qi3,4,5, Duan Ni2
1School of Medical Laboratory, Weifang Medical University, Weifang 261053, China.
Abstract:
Mutations in leucine-rich repeat kinase 2 (LRRK2) are recognized as the most frequent cause of Parkinson's disease (PD). As a multidomain ROCO protein, LRRK2 is characterized by the presence of both a Ras-of-complex (ROC) GTPase domain and a kinase domain connected through the C-terminal of an ROC domain (COR). The bienzymatic ROC-COR-kinase catalytic triad indicated the potential role of GTPase domain in regulating kinase activity. However, as a functional GTPase, the detailed intrinsic regulation of the ROC activation cycle remains poorly understood. Here, combining extensive molecular dynamics simulations and Markov state models, we disclosed the dynamic structural rearrangement of ROC's homodimer during nucleotide turnover. Our study revealed the coupling between dimerization extent and nucleotide-binding state, indicating a nucleotide-dependent dimerization-based activation scheme adopted by ROC GTPase. Furthermore, inspired by the well-known R1441C/G/H PD-relevant mutations within the ROC domain, we illuminated the potential allosteric molecular mechanism for its pathogenetic effects through enabling faster interconversion between inactive and active states, thus trapping ROC in a prolonged activated state, while the implicated allostery could provide further guidance for identification of regulatory allosteric pockets on the ROC complex. Our investigations illuminated the thermodynamics and kinetics of ROC homodimer during nucleotide-dependent activation for the first time and provided guidance for further exploiting ROC as therapeutic targets for controlling LRRK2 functionality in PD treatment.
Insights
Parkinson's disease mutations in leucine-rich repeat kinase 2 (LRRK2) involve its ROC GTPase domain. We found nucleotide binding controls ROC homodimerization, revealing a new activation mechanism and potential therapeutic targets for Parkinson's disease.
Area of Science:
- Biochemistry and Molecular Biology
- Neuroscience
- Computational Biology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) mutations are the leading genetic cause of Parkinson's disease (PD).
- LRRK2 is a ROCO protein with linked GTPase (ROC) and kinase domains, suggesting GTPase activity regulates kinase function.
- The intrinsic regulation of the ROC GTPase activation cycle remains poorly understood.
Purpose of the Study:
- To elucidate the dynamic structural rearrangements of the ROC GTPase homodimer during nucleotide turnover.
- To understand the nucleotide-dependent activation mechanism of the ROC GTPase.
- To investigate the allosteric mechanisms underlying PD-relevant mutations in the ROC domain.
Main Methods:
- Extensive molecular dynamics simulations.
- Markov state models analysis.
- Investigation of nucleotide turnover and dimerization dynamics.
Main Results:
- Disclosed dynamic structural rearrangements of the ROC homodimer during nucleotide turnover.
- Revealed coupling between dimerization extent and nucleotide-binding state, establishing a nucleotide-dependent dimerization-based activation scheme.
- Illuminated potential allosteric mechanisms for PD-relevant mutations, suggesting they trap ROC in a prolonged active state.
Conclusions:
- The study provides the first comprehensive understanding of ROC homodimer thermodynamics and kinetics during nucleotide-dependent activation.
- Identified a novel nucleotide-dependent dimerization-based activation mechanism for ROC GTPase.
- The findings offer guidance for developing therapeutic strategies targeting ROC allosteric pockets to control LRRK2 in PD treatment.
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Cooperative Allosteric Transitions
Receptor Tyrosine Kinases
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Molecular Models
MAPK Signaling Cascades

